EXECUTIVE ENGAGEMENTS
OUTREACH
419
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
84
Interactions with Platform & by Email
PARTICIPANTS
17
Unique # Participated
VALIDATIONS
8
Responses Validated*
COMPETITORS
42
Responses Validated*
BRANDS
286
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
111
PAGES
183
EDITION
6
PRICE
USD $4950
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Viral Inactivation estimated at US$443.1 Million in the year 2020, is projected to reach a revised size of US$951.1 Million by 2027, growing at a CAGR of 11.5% over the analysis period 2020-2027. Kits & Reagents, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$549.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Systems segment is readjusted to a revised 12.1% CAGR for the next 7-year period.
The Viral Inactivation market in the U.S. is estimated at US$130.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$166.8 Million by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 10.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$57.2 Million in the year 2020 will reach a projected size of US$115.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$112.3 Million by the year 2027.
SELECT PLAYERS
Charles River Laboratories International, Inc.; Clean Cells Inc.; Danaher Corporation; Merck KgaA; Parker Hannifin Corporation; Rad Source Technologies, Inc.; Sartorius AG; SGS Group (SGS SA); Texcell, Inc.; V.I.P.S. SA; WuXi AppTec Group
SEGMENTS
» Application (Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products, Cellular and Gene Therapy) » Product (Kits & Reagents, Systems, Services)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Viral Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Viral Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Viral Inactivation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Vaccines and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Vaccines and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Vaccines and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Stem Cell Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Stem Cell Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Stem Cell Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Blood and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Blood and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Blood and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Tissue/ Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Tissue/ Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Tissue/ Tissue Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cellular and Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cellular and Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cellular and Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Viral Inactivation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Viral Inactivation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Viral Inactivation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 42 |
The U.S. Economy is Reinventing Itself to Weather Economic Storms.
Here's An Analytical Window into the Changing Opportunities.
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com